Abingworth closes biotech fund
At $225m, Bioventures III LP closed $75m over its initial target, said the UK-based venture capitalist.
29 January 2013•2 mins read
Infrastructure InvestorAt $225m, Bioventures III LP closed $75m over its initial target, said the UK-based venture capitalist.